Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2026-04-30 @ 4:52 AM
Study NCT ID:
NCT00633750
Status:
COMPLETED
Last Update Posted:
2012-09-05
First Post:
2008-03-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VICC BRE 0222
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |